US 11851471
T-cell modulatory multimeric polypeptides and methods of use thereof
granted A61KA61K35/17A61K38/00
Quick answer
US patent 11851471 (T-cell modulatory multimeric polypeptides and methods of use thereof) held by Cue Biopharma, Inc. expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cue Biopharma, Inc.
- Grant date
- Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K35/17, A61K38/00, A61K39/00111, A61K39/39558